Some sarcoma subtypes such as synovial sarcoma and myxoid/round cell liposarcoma characterized as “cold” tumours without high expression of MHC-I and T-cells infiltration, may turn into hot tumours by IFNγ and thus may benefit from combination treatment with IFNγ and other immunotherapy strategies. This evidence concerns the gene IFNG and sarcoma.